Cereno Insights Series: Clinical Trials in PAH with Dr Raymond Benza

Professor Raymond Benza, Principal Investigator for Cereno’s CS1 trial, speaking more in-depth on clinical trials in PAH. In particular, he speaks around the following questions:

• Are there any particular challenges in clinical trial design for studying treatments for PAH?
• What are the key elements in an optimized PAH trial design?
• Can you elaborate on the optimal choice of primary and secondary trial endpoints and how this has evolved over the past 5 to 10 years?
• Traditionally, PH therapies have been evaluated in trials versus placebo. Do you think future studies would more likely be head-to-head drug therapy studies?

English subtitles are available. (Recorded at the ESC Congress in August 2022)

Watch here >